In 77 adults with CIDP on IVIg, adding IV methylprednisolone did not significantly increase 52-week remission vs placebo (38% vs 28%; p=0.47); the trial stopped early after 4 thromboembolic events in the methylprednisolone group vs none with placebo.
RCTn = 77
Bus et al. Intravenous methylprednisolone as add-on induction therapy for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial